Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge

The demonstrated clinical efficacy of a recombinant vesicular stomatitis virus (rVSV) vaccine vector has stimulated the investigation of additional serologically distinct Vesiculovirus vectors as therapeutic and/or prophylactic vaccine vectors to combat emerging viral diseases. Among these viral thr...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Virol
Auteurs principaux: Nasar, Farooq, Matassov, Demetrius, Seymour, Robert L., Latham, Theresa, Gorchakov, Rodion V., Nowak, Rebecca M., Leal, Grace, Hamm, Stefan, Eldridge, John H., Tesh, Robert B., Clarke, David K., Weaver, Scott C.
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2017
Sujets:
Vaccines and Antiviral Agents
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5375677/
https://ncbi.nlm.nih.gov/pubmed/28148802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.01729-16
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires